Novo Nordisk ha scelto gli Emirati Arabi Uniti per il primo lancio internazionale della versione orale di Wegovy, segnando

Novo's approach to global launches will be guided by patient demand and the strength of healthcare and telehealth infrastructure, the drugmaker said.

A launch in the United Arab Emirates comes as Novo works to recover ground in the weight loss drug market against rival Eli Lilly